Parkinson Disease Publications

News & Events | Giving | Success Stories | Contact Us |

	Core Programs

	CHG Resources

	Publications

	Age-Related Macular Degeneration (AMD) Amyotrophic Lateral Sclerosis (ALS) Chiari Malformations and Syringomyelia Early Onset Cardiovascular Disease Essential Tremer Facioscapulohumeral Muscular Dystrophy Focal Segmental Glomerulosclerosis (FSGS) Glaucoma Limb-Girdle Muscular Dystrophy Multiple Sclerosis (MS) Myopia Neural Tube Defects (NTD) Parkinson Disease

Publications

Parkinson Disease

Oliveira SA, Li JY, Noureddine MA, Züchner S, Qin X, Pericak-Vance MA, Vance JM. Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am J Hum Genet. 2005 Aug;77(2):252-64. Epub 2005 Jun 28.

Li Y-J, Scott WK, Zhang L, Lin P-I, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, Pericak-Vance MA, Vance JM (Pericak-Vance MA and Vance JM contributed equally to this manuscript as joint senior authors). Revealing the role of Glutathione S-Transferase Omega-1 in age-at-onset of Alzheimer and Parkinson Diseases. Neurobiol Aging. 2005 Jun 25; [Epub ahead of print].

Noureddine MA, Qin X-J, Oliveira SA, Skelly TA, van der Walt JM, Hauser MA, PERICAK VANCE MA, Vance JM, Li Y-J. Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet. 2005 Jun;117(1):27-33. Epub 2005 Apr 13.

Oliveira SA, Scott WK, Zhang F, Stajich JM, Fujiwara K, Hauser M, Scott BL, Pericak-Vance MA, Vance JM, Martin ER. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype. Neurogenetics. 2004 Sep;5(3):147-55.

Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Haines JL, Pericak-Vance MA, Vance JM. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 62(11):2005-9, 2004.

Van Der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R, Zhang F, Stajich JM, Fujiwara K, Scott BL, Pericak-Vance MA, Vance JM, Martin ER. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet. 74(6):1121-7, 2004.

Li Y-J, Oliveira SA, Xu P, Martin ER, Stenger JE, Hulette C, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Welsh-Bohmer KA, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, and Pericak-Vance MA. Glutathione S-Transferase modifies age-at-onset of Alzheimer Disease and Parkinson Disease. Human Molecular Genetics (12) 24:1-9, 2003.

Pericak-Vance MA, Scott WK, Martin ER, Vance JM, Haines, JL. Identifying genetic factors in Parkinson disease [reply]. Letter to the Editor, JAMA 2002; 287(6) 715-716.

Oliveira SA, Scott WK, Martin ER, Pericak-Vance MA, Vance JM. Frequency of Parkin mutations in late-onset Parkinson disease [reply]. Letter to the Editor, Ann Neurol. 2003 May;53(5):624-9.

Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen Jr. FH, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol 60(7):975-80, 2003.

Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen Jr. FH, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol 53:624-629, 2003.

van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr. FH, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72(4):804-811, 2003.

van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, VANCE JM. Genetic polymorphisms of the N-acetyltransferase genes (NAT1 and NAT2) and risk to Parkinson's disease. Neurology 60(7):1189-1191, 2003.

Hauser MA, Li YJ; Takeuchi S, Walters R, Noureddine M, Maready M, Darden T, Hulette C, Martin E, Hauser E, Xu H, Schmechel D, Stenger J, Dietrich, F; Vance,J. Genomic convergence: Identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Human Molecular Genetics 12(6):1-7, 2003.

Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen Jr FA, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70(4):985-93, 2002.

Scott WK, Vance JM, Haines JL, and Pericak-Vance MA. Linkage of Parkinsonism and Alzheimer's disease with Lewy body pathology to chromosome 12. Ann Neurology 52(4):524, 2002.

Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr. FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck BD, Booze MW, Ribble RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA for the Duke Center for Human Genetics (DCHG)/Deane Laboratory/GlaxoSmithKline Parkinson Disease Genetics Collaboration. Complete genomic screen in Parkinson Disease: Evidence for multiple genes. JAMA 286:2239-2244, 2001.

Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr. FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Ribble RC, Booze MW, Rogala A, Hauser MA, Zhang F, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, for the Duke Center for Human Genetics (DCHG)/Deane Laboratory/GlaxoSmithKline Parkinson Disease Genetics Collaboration. Association analysis of the tau gene with late-onset Parkinson disease: Association with intragenic single nucleotide polymorphisms. JAMA 286:2245-2250, 2001.

Scott WK, Yamaoka LH, Stajich JM, Scott BL, Vance JM, Roses AD, Pericak-Vance MA, and the Deane Laboratory Parkinson Disease Research Group. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics 2:191-192, 1999.

Hulette CM, Pericak-Vance MA, Roses AD, Schmechel DE, Yamaoka LH, Gaskell PC, Welsh-Bohmer KA, Crowther RA, Spillantini MG. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684. J Neuropathology Exp Neurology 58(8):859-66, 1999.

Lavedan C, Buchholtz S, Auburger G, Albin RL, Athanassiadou A, Blancato J, Burguera JA, Ferrell RE, Kostic V, Leroy E, Leube B, Mota-Vieira L, Papapetropoulos T, Pericak-Vance MA, Pinkus J, Scott WK, Ulm G, Vasconcelos J, Vilchez JJ, Nussbaum RL. Polymeropoulos MH. Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease. DNA Research 5(6):401-2, 1998.

Scott WK, Stajich JM, Yamaoka LH, Speer MC, Vance JM, Roses AD, Pericak-Vance MA, and the Deane Laboratory Parkinson Disease Research Group. The genetic complexity of Parkinson Disease. Science 277:387-388, 1997.

// top //